Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Biosimilar entrants compress price points for mature insulins and DPP-4 inhibitors, pressuring innovators to pivot toward differentiated GLP-1 and dual-agonist pipelines
In others, they can delay or disrupt ovulation temporarily
Phytotherapy Research, 20 (12), 1036-1039
Additional TRIUMPH trials are expected to report through 2026 before an NDA can be submitted
Typically, an initial series of treatments may be recommended, ranging from once to twice a week over four to eight weeks
2025 formulary: Effective January 1, 2025
US$ 27.10
US$ 23.91
US$ 24.72
US$ 24.47
US$ 25.17
US$ 20.58
US$ 21.19
